We are live on ! Find out more
XBIO icon

Xenetic Biosciences
XBIO

6 hedge funds and large institutions have $682K invested in Xenetic Biosciences in 2017 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more funds holding

Funds holding: 4 → 6 (+2)

0.12% more ownership

Funds ownership: 3.75% → 3.87% (+0.12%)

24% less capital invested

Capital invested by funds: $902K → $682K (-$220K)

Holders
6
Holders Change
+2
Holders Change %
+50%
% of All Funds
0.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PAM
Panagora Asset Management
Massachusetts
+$18.4K
2
UBS Group
UBS Group
Switzerland
+$3.88K

Top Sellers

No sellers this quarter

XBIO Hedge Fund Activity: Q3 2017 in Review

6 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Xenetic Biosciences (XBIO) for Q3 2017, worth a combined $682K — down 24% from $902K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new XBIO positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Panagora Asset Management, opening a new position worth an estimated $18.4K.

  • 6 institutional investors held Xenetic Biosciences (XBIO) as of Q3 2017, up from 4 in Q2 2017.
  • Funds reported $682K of Xenetic Biosciences stock for Q3 2017, down 24% quarter-over-quarter.
  • 2 funds opened new Xenetic Biosciences positions in Q3 2017 and 0 closed out, a net change of +2 holders.
  • The largest Xenetic Biosciences buyer in Q3 2017 was Panagora Asset Management, an estimated $18.4K added.

Based on aggregated 13F filings for Q3 2017.